Moxifloxacin
Showing 1 - 25 of 649
Cataract Trial in Jakarta Pusat (Moxifloxacin Ophthalmic Solution, Levofloxacin Ophthalmic)
Recruiting
- Cataract
- Moxifloxacin Ophthalmic Solution
- Levofloxacin Ophthalmic
-
Jakarta Pusat, DKI Jakarta, IndonesiaFakultas Kedokteran Universitas Indonesia
Feb 23, 2023
HSV Infection Trial in London (Pritelivir and moxifloxacin , Pritelivir , moxifloxacin and moxifloxacin , Pritelivir ,
Recruiting
- HSV Infection
- Pritelivir and moxifloxacin placebo
- +2 more
-
London, United KingdomRichmond Pharmacology Ltd
Jan 3, 2023
Helicobacter Pylori Infection, Helicobacter Pylori Infection, Susceptibility to Trial in Karachi (Sequential Regimen:
Completed
- Helicobacter Pylori Infection
- Helicobacter Pylori Infection, Susceptibility to
- Sequential Regimen: Levofloxacin 500 mg BID, Amoxicillin 1 gm BID, omeprazole 20 mg BID for first five days followed by Levofloxacin 500 mgBID, Tinidazole 500 mg BID, Omeprazole 20 mg BID
- Triple Regimen: Moxifloxacin 400mg OD, Amoxicillin 1 gm BID, Omeprazole 20mgBID
-
Karachi, Sindh, PakistanJamal Noor Hospital, Karachi
May 8, 2023
Endophthalmitis, Macula Edema, Cataract Trial in Campinas (Moxifloxacin Injection)
Completed
- Endophthalmitis
- +2 more
- Moxifloxacin Injection
-
Campinas, São Paulo, BrazilHospital das Clínicas da UNICAMP
Nov 2, 2022
Healthy Individuals, Bioequivalence Study Trial in Karachi (Moxifloxacin 400mg)
Completed
- Healthy Individuals
- Bioequivalence Study
- Moxifloxacin 400mg
-
Karachi, Sindh, PakistanCenter for Bioequivalence Studies and clinical research
Sep 5, 2022
Obesity Trial in Berlin (Cagrilintide, Cagrilintide Placebo, Moxifloxacin)
Not yet recruiting
- Obesity
- Cagrilintide
- +3 more
-
Berlin, GermanyNovo Nordisk Investigational Site
Mar 27, 2023
0.5% Moxifloxacin Hydrochloride Ophthalmic Solution in
Not yet recruiting
- Post Operative Endophthalmitis
- Moxifloxacin hydrochloride ophthalmic solution
- (no location specified)
Jan 11, 2023
Endophthalmitis Trial in Saint George (Moxifloxacin, Placebo)
Not yet recruiting
- Endophthalmitis
- Moxifloxacin
- Placebo
-
Saint George, UtahZion Eye Institute
Dec 31, 2022
Healthy Trial in Overland Park (Rodatristat Ethyl, Moxifloxacin, Placebo for Rodatristat)
Recruiting
- Healthy
- Rodatristat Ethyl
- +3 more
-
Overland Park, KansasAltasciences Clinical Kansas, Inc.
Jul 5, 2023
Triple Negative Breast Cancer Trial in Guangzhou (Gemcitabine and carboplatin plus antibiotic (moxifloxacin), Gemcitabine
Recruiting
- Triple Negative Breast Cancer
- Gemcitabine and carboplatin plus antibiotic (moxifloxacin)
- Gemcitabine combined with carboplatin plus placebo
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Nov 6, 2022
Pharmacological Action Trial in Tahta (intra-vitreal triamcinolone-moxifloxacin injection after cataract surgery as a
Completed
- Pharmacological Action
- intra-vitreal triamcinolone-moxifloxacin injection after cataract surgery as a prophylactic measures against post-operative endophthalmitis
-
Tahta, Sohag, EgyptEmad AbdelAal Saliem
Jun 23, 2022
Non-alcoholic Steatohepatitis Trial in Berlin (Cotadutide, Cotadutide-, Moxifloxacin)
Recruiting
- Non-alcoholic Steatohepatitis
- Cotadutide
- +3 more
-
Berlin, GermanyResearch Site
Jan 16, 2023
Healthy Trial (BI 1015550, Moxifloxacin, Placebo)
Not yet recruiting
- Healthy
- BI 1015550
- +2 more
- (no location specified)
Nov 2, 2023
Asthma, COPD (COPD) Trial in Baltimore (CHF5993, CHF5259, Moxifloxacin 400mg)
Recruiting
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
- CHF5993
- +3 more
-
Baltimore, MarylandPAREXEL Baltimore Early Phase Clinical Unit
Apr 13, 2023
Health Adult Subjects Trial (Omaveloxolone, Moxifloxacin)
Not yet recruiting
- Health Adult Subjects
- Omaveloxolone
- Moxifloxacin
- (no location specified)
Jun 28, 2023
Cardiac Arrhythmias Trial in Boston (Moxifloxacin 400mg once time)
Terminated
- Cardiac Arrhythmias
- Moxifloxacin 400mg once time
-
Boston, MassachusettsMassachusetts General Hospital
Dec 23, 2021
Tuberculosis, Human Immunodeficiency Virus Trial (Optimised rifamycin)
Not yet recruiting
- Tuberculosis
- Human Immunodeficiency Virus
- Optimised rifamycin
- (no location specified)
Oct 8, 2022
Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men, Hot Flashes, Healthy Volunteers Trial in Neu-Ulm
Not yet recruiting
- Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men
- +2 more
- Moxifloxacin
- +2 more
-
Neu-Ulm, Bayern, GermanyNUVISAN GmbH
Jul 28, 2022
Bioequivalence Trial in Karachi (Moksi® 400mg Tablet, Drug: Avelox® 400Mg Tablet)
Completed
- Bioequivalence
- Moksi® 400mg Tablet
- Drug: Avelox® 400Mg Tablet
-
Karachi, Sindh, PakistanCenter for Bioequivalence Studies and Clinical Research (CBSCR)
Mar 31, 2022
Infections Joint Prosthetic Trial in France (amoxicillin or moxifloxacin, amoxicillin or moxifloxacin + rifampicin)
Not yet recruiting
- Infections Joint Prosthetic
- amoxicillin or moxifloxacin
- amoxicillin or moxifloxacin + rifampicin
-
Annecy, France
- +11 more
Jun 5, 2023